Fulgent Genetics, Inc. Q3 Earnings Summary

Below are the earnings highlights for Fulgent Genetics, Inc. (FLGT):

Earnings: -$14.648 million in Q3 vs. -$13.107 million in the same period last year.
EPS: -$0.48 in Q3 vs. -$0.44 in the same period last year.
Excluding items, Fulgent Genetics, Inc. reported adjusted earnings of $9.438 million or $0.31 per share for the period.

Analysts projected -$0.15 per share
Revenue: $71.743 million in Q3 vs. $84.687 million in the same period last year.

-Guidance:
Full year EPS guidance: $0.33
Full year revenue guidance: Around $280 Mln

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com